The Role of Amylin and Glucagon in T1DM

Completed · Phase 3

Conditions studied: Type 1 Diabetes

In brief

The purpose of this study is to see if giving pramlintide and insulin before a meal would lower high blood sugar and if a glucagon (a naturally made hormone in the body but reduced in diabetes and its role is in prevention of low blood sugar) shot given in the late "after meal" time would prevent low blood sugar. The studies outlined in this proposal might help in developing new treatment options to target "after meal" high blood sugar and before meal low blood sugar in children. This would possibly help improve overall blood sugar control and prevent the long-term complications of diabetes.

Key facts

Study ID
NCT00206258
Run by
Baylor College of Medicine
People needed
30
Starts
2002-07-01
Expected to finish
2005-08-01
Last updated by the study team
2016-07-14

Who can join

Age: 12 and older, up to 21. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.